Is there any value in measuring faecal calprotectin in Clostridium difficile positive faecal samples?
Markers of intestinal inflammation have been proposed for inclusion in Clostridium difficile diagnostic algorithms. Faecal calprotectin (f-Cp), a sensitive marker of intestinal inflammation, was evaluated for utility in C. difficile diagnosis in the hospital setting. One hundred and twenty C. diffic...
Saved in:
| Published in | Journal of medical microbiology Vol. 63; no. 4; pp. 590 - 593 |
|---|---|
| Main Authors | , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Reading
Society for General Microbiology
01.04.2014
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 0022-2615 1473-5644 1473-5644 |
| DOI | 10.1099/jmm.0.067389-0 |
Cover
| Abstract | Markers of intestinal inflammation have been proposed for inclusion in
Clostridium difficile
diagnostic algorithms. Faecal calprotectin (f-Cp), a sensitive marker of intestinal inflammation, was evaluated for utility in
C. difficile
diagnosis in the hospital setting. One hundred and twenty
C. difficile
positive and 99
C. difficile
negative faecal samples of hospital-acquired diarrhoea were analysed for f-Cp using a quantitative ELISA.
C. difficile
positivity was confirmed using ELISAs for either toxins (
n
= 45) or glutamate dehydrogenase (GDH) with toxin gene confirmation (
n
= 75). Non-parametric ANOVA (Kruskal–Wallis) was used for data analysis.
C. difficile
positive samples had higher (
P
<0.05) median (interquartile range) f-Cp levels; 336 µg g
−1
(208–536) for toxin and 249 µg g
−1
(155–498) for GDH and toxin gene positive compared with 106 µg g
−1
(46–176) for
C. difficile
and culture-negative faecal samples. Five
C. difficile
positive samples were f-Cp negative (<50 µg g
−1
). A f-Cp concentration >50 µg g
−1
was 96 % sensitive and 26 % specific for
C. difficile
, with area under the ROC curve of 0.82. There is no role for f-CP alone in predicting
C. difficile
infection in hospital-acquired diarrhoea due to its low specificity. |
|---|---|
| AbstractList | Markers of intestinal inflammation have been proposed for inclusion in
Clostridium difficile
diagnostic algorithms. Faecal calprotectin (f-Cp), a sensitive marker of intestinal inflammation, was evaluated for utility in
C. difficile
diagnosis in the hospital setting. One hundred and twenty
C. difficile
positive and 99
C. difficile
negative faecal samples of hospital-acquired diarrhoea were analysed for f-Cp using a quantitative ELISA.
C. difficile
positivity was confirmed using ELISAs for either toxins (
n
= 45) or glutamate dehydrogenase (GDH) with toxin gene confirmation (
n
= 75). Non-parametric ANOVA (Kruskal–Wallis) was used for data analysis.
C. difficile
positive samples had higher (
P
<0.05) median (interquartile range) f-Cp levels; 336 µg g
−1
(208–536) for toxin and 249 µg g
−1
(155–498) for GDH and toxin gene positive compared with 106 µg g
−1
(46–176) for
C. difficile
and culture-negative faecal samples. Five
C. difficile
positive samples were f-Cp negative (<50 µg g
−1
). A f-Cp concentration >50 µg g
−1
was 96 % sensitive and 26 % specific for
C. difficile
, with area under the ROC curve of 0.82. There is no role for f-CP alone in predicting
C. difficile
infection in hospital-acquired diarrhoea due to its low specificity. Markers of intestinal inflammation have been proposed for inclusion in Clostridium difficile diagnostic algorithms. Faecal calprotectin (f-Cp), a sensitive marker of intestinal inflammation, was evaluated for utility in C. difficile diagnosis in the hospital setting. One hundred and twenty C. difficile positive and 99 C. difficile negative faecal samples of hospital-acquired diarrhoea were analysed for f-Cp using a quantitative ELISA. C. difficile positivity was confirmed using ELISAs for either toxins (n = 45) or glutamate dehydrogenase (GDH) with toxin gene confirmation (n = 75). Non-parametric ANOVA (Kruskal-Wallis) was used for data analysis. C. difficile positive samples had higher (P<0.05) median (interquartile range) f-Cp levels; 336 µg g(-1) (208-536) for toxin and 249 µg g(-1) (155-498) for GDH and toxin gene positive compared with 106 µg g(-1) (46-176) for C. difficile and culture-negative faecal samples. Five C. difficile positive samples were f-Cp negative (<50 µg g(-1)). A f-Cp concentration >50 µg g(-1) was 96 % sensitive and 26 % specific for C. difficile, with area under the ROC curve of 0.82. There is no role for f-CP alone in predicting C. difficile infection in hospital-acquired diarrhoea due to its low specificity. Markers of intestinal inflammation have been proposed for inclusion in Clostridium difficile diagnostic algorithms. Faecal calprotectin (f-Cp), a sensitive marker of intestinal inflammation, was evaluated for utility in C. difficile diagnosis in the hospital setting. One hundred and twenty C. difficile positive and 99 C. difficile negative faecal samples of hospital-acquired diarrhoea were analysed for f-Cp using a quantitative ELISA. C. difficile positivity was confirmed using ELISAs for either toxins (n = 45) or glutamate dehydrogenase (GDH) with toxin gene confirmation (n = 75). Non-parametric ANOVA (Kruskal-Wallis) was used for data analysis. C. difficile positive samples had higher (P<0.05) median (interquartile range) f-Cp levels; 336 µg g(-1) (208-536) for toxin and 249 µg g(-1) (155-498) for GDH and toxin gene positive compared with 106 µg g(-1) (46-176) for C. difficile and culture-negative faecal samples. Five C. difficile positive samples were f-Cp negative (<50 µg g(-1)). A f-Cp concentration >50 µg g(-1) was 96 % sensitive and 26 % specific for C. difficile, with area under the ROC curve of 0.82. There is no role for f-CP alone in predicting C. difficile infection in hospital-acquired diarrhoea due to its low specificity.Markers of intestinal inflammation have been proposed for inclusion in Clostridium difficile diagnostic algorithms. Faecal calprotectin (f-Cp), a sensitive marker of intestinal inflammation, was evaluated for utility in C. difficile diagnosis in the hospital setting. One hundred and twenty C. difficile positive and 99 C. difficile negative faecal samples of hospital-acquired diarrhoea were analysed for f-Cp using a quantitative ELISA. C. difficile positivity was confirmed using ELISAs for either toxins (n = 45) or glutamate dehydrogenase (GDH) with toxin gene confirmation (n = 75). Non-parametric ANOVA (Kruskal-Wallis) was used for data analysis. C. difficile positive samples had higher (P<0.05) median (interquartile range) f-Cp levels; 336 µg g(-1) (208-536) for toxin and 249 µg g(-1) (155-498) for GDH and toxin gene positive compared with 106 µg g(-1) (46-176) for C. difficile and culture-negative faecal samples. Five C. difficile positive samples were f-Cp negative (<50 µg g(-1)). A f-Cp concentration >50 µg g(-1) was 96 % sensitive and 26 % specific for C. difficile, with area under the ROC curve of 0.82. There is no role for f-CP alone in predicting C. difficile infection in hospital-acquired diarrhoea due to its low specificity. |
| Author | Ford, Clare Shipman, Kate E. Gama, Rousseau Whitehead, Simon J. Cooper, Mike |
| Author_xml | – sequence: 1 givenname: Simon J. surname: Whitehead fullname: Whitehead, Simon J. organization: Department of Clinical Chemistry, New Cross Hospital, Wolverhampton, UK – sequence: 2 givenname: Kate E. surname: Shipman fullname: Shipman, Kate E. organization: Department of Clinical Chemistry, New Cross Hospital, Wolverhampton, UK – sequence: 3 givenname: Mike surname: Cooper fullname: Cooper, Mike organization: Microbiology, New Cross Hospital, Wolverhampton, UK – sequence: 4 givenname: Clare surname: Ford fullname: Ford, Clare organization: Department of Clinical Chemistry, New Cross Hospital, Wolverhampton, UK – sequence: 5 givenname: Rousseau surname: Gama fullname: Gama, Rousseau organization: Research Institute, Healthcare Sciences, Wolverhampton University, Wolverhampton, UK, Department of Clinical Chemistry, New Cross Hospital, Wolverhampton, UK |
| BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=28392015$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/24464697$$D View this record in MEDLINE/PubMed |
| BookMark | eNp1kU2LFDEQhoOsuLOrV4_SF8FLj5XPnpxEBnUXFrzoOVSnqzVLuntM0gv7780yMwjCUilyqOetSuW9YhfzMhNjbzlsOVj78X6atrAF08mdbeEF23DVyVYbpS7YBkCIVhiuL9lVzvcAvJPSvmKXQimjjO02jG5zU35Togbnx-YB40pNmJuJMK8pzL-aEcljbGoe0lLIl1qtZx-XXFIYwjo1QxjH4EOk5rDkUMIDnVUZp0Ok_Ok1ezlizPTmdF-zn1-__NjftHffv93uP9-1XgpdWhwUwaiERVTcGL3rrbViUH6AGsR7gVIOpLlFsJ0F02vNewkGdr4ftZfX7MOxb33rn5VycVPInmLEmZY1O645gAUNUNF3J3TtJxrcIYUJ06M7f00F3p8AzHWXMeHsQ_7H7aQVwHXl1JHzack50eh8KFjCMpeEIToO7skpV51y4I5Ouaf52_9k587PCP4C0FaV3w |
| CODEN | JMMIAV |
| CitedBy_id | crossref_primary_10_1007_s10096_017_3080_y crossref_primary_10_3389_fphys_2022_881816 crossref_primary_10_1136_bmj_l4609 crossref_primary_10_33192_smj_v76i4_267058 crossref_primary_10_1080_00365521_2017_1392598 crossref_primary_10_3343_alm_2017_37_1_53 crossref_primary_10_1128_JCM_02230_15 crossref_primary_10_1007_s10096_018_3381_9 crossref_primary_10_1093_cid_cix669 crossref_primary_10_1186_s12879_016_1618_8 crossref_primary_10_1371_journal_pone_0106118 crossref_primary_10_1016_j_idc_2014_11_008 |
| Cites_doi | 10.1111/j.1651-2227.2010.01843.x 10.1136/fg.2010.001362 10.1111/1469-0691.12057 10.1258/acb.2012.011272 10.1046/j.1365-2036.2002.01196.x 10.1016/j.jhin.2013.05.006 10.1128/CMR.00016-13 10.1097/MPG.0b013e318262a718 10.1111/j.1469-0691.2009.03098.x 10.1128/JCM.02735-12 10.3109/00365521.2013.775329 10.1001/archinte.1996.00440120107012 10.1016/j.amjmed.2008.06.034 10.1080/09674845.2009.11730269 10.1038/ng.2478 |
| ContentType | Journal Article |
| Copyright | 2015 INIST-CNRS |
| Copyright_xml | – notice: 2015 INIST-CNRS |
| DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1099/jmm.0.067389-0 |
| DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | CrossRef MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Biology |
| EISSN | 1473-5644 |
| EndPage | 593 |
| ExternalDocumentID | 24464697 28392015 10_1099_jmm_0_067389_0 |
| Genre | Evaluation Study Journal Article |
| GroupedDBID | --- -~X 18M 2WC 4.4 53G 5GY 5RE 5RS AAYEP AAYXX ABOCM ACGFO ACPEE ADBBV ADCDP AENEX ALMA_UNASSIGNED_HOLDINGS BAWUL C45 CITATION CS3 DIK DU5 E3Z EBS EJD F5P GX1 H13 L7B M5~ OBC OBS OEB OFXIZ OK1 OVD OWW P0W P2P RGM TEORI TR2 VVN W8F WOQ YFH YQY .55 .GJ 08G 1KJ 3O- 5VS AAKAS ACBNA ADZCM AFFNX AFOSN AI. AJKYU CAG COF EX3 IQODW NTWIH OHT VH1 WOW X7M YQJ ZE2 ZGI ZXP AWKKM CGR CUY CVF ECM EIF NPM PKN 7X8 |
| ID | FETCH-LOGICAL-c325t-ad4e0f429aa416658b9992d4cd0d0de1b2a33de519a097906b551b30608cbf5c3 |
| ISSN | 0022-2615 1473-5644 |
| IngestDate | Thu Sep 04 15:19:24 EDT 2025 Wed Feb 19 02:31:24 EST 2025 Wed Apr 02 07:20:33 EDT 2025 Wed Oct 01 03:34:32 EDT 2025 Thu Apr 24 23:03:19 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 4 |
| Keywords | Clostridiales Bacteria Feces Clostridiaceae Clostridium difficile |
| Language | English |
| License | CC BY 4.0 |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c325t-ad4e0f429aa416658b9992d4cd0d0de1b2a33de519a097906b551b30608cbf5c3 |
| Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Undefined-1 ObjectType-Feature-3 content type line 23 |
| PMID | 24464697 |
| PQID | 1510090500 |
| PQPubID | 23479 |
| PageCount | 4 |
| ParticipantIDs | proquest_miscellaneous_1510090500 pubmed_primary_24464697 pascalfrancis_primary_28392015 crossref_citationtrail_10_1099_jmm_0_067389_0 crossref_primary_10_1099_jmm_0_067389_0 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2014-04-01 |
| PublicationDateYYYYMMDD | 2014-04-01 |
| PublicationDate_xml | – month: 04 year: 2014 text: 2014-04-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | Reading |
| PublicationPlace_xml | – name: Reading – name: England |
| PublicationTitle | Journal of medical microbiology |
| PublicationTitleAlternate | J Med Microbiol |
| PublicationYear | 2014 |
| Publisher | Society for General Microbiology |
| Publisher_xml | – name: Society for General Microbiology |
| References | r2 r3 r4 r5 r7 r9 (r8) 2006 r10 r12 r11 r14 r13 Lamb (r3a) 2011; 2 r15 Wren (r16) 2009; 66 (r6) 2012 r1 |
| References_xml | – ident: r13 doi: 10.1111/j.1651-2227.2010.01843.x – volume-title: Updated guidance on the diagnosis and reporting of Clostridium difficile year: 2012 ident: r6 – volume: 2 start-page: 13 year: 2011 ident: r3a article-title: Measurement of faecal calprotectin and lactoferrin in inflammatory bowel disease publication-title: Frontline Gastroenterol doi: 10.1136/fg.2010.001362 – ident: r15 doi: 10.1111/1469-0691.12057 – ident: r14 doi: 10.1258/acb.2012.011272 – ident: r11 doi: 10.1046/j.1365-2036.2002.01196.x – volume-title: Investigation into outbreaks of Clostridium difficile at Stoke Mandeville Hospital, Buckinghamshire Hospitals NHS Trust year: 2006 ident: r8 – ident: r1 doi: 10.1016/j.jhin.2013.05.006 – ident: r3 doi: 10.1128/CMR.00016-13 – ident: r4 doi: 10.1097/MPG.0b013e318262a718 – ident: r5 doi: 10.1111/j.1469-0691.2009.03098.x – ident: r9 doi: 10.1128/JCM.02735-12 – ident: r10 doi: 10.3109/00365521.2013.775329 – ident: r2 doi: 10.1001/archinte.1996.00440120107012 – ident: r12 doi: 10.1016/j.amjmed.2008.06.034 – volume: 66 start-page: 175 year: 2009 ident: r16 article-title: Detection of Clostridium difficile infection: a suggested laboratory diagnostic algorithm publication-title: Br J Biomed Sci doi: 10.1080/09674845.2009.11730269 – ident: r7 doi: 10.1038/ng.2478 |
| SSID | ssj0017339 |
| Score | 2.1724167 |
| Snippet | Markers of intestinal inflammation have been proposed for inclusion in
Clostridium difficile
diagnostic algorithms. Faecal calprotectin (f-Cp), a sensitive... Markers of intestinal inflammation have been proposed for inclusion in Clostridium difficile diagnostic algorithms. Faecal calprotectin (f-Cp), a sensitive... |
| SourceID | proquest pubmed pascalfrancis crossref |
| SourceType | Aggregation Database Index Database Enrichment Source |
| StartPage | 590 |
| SubjectTerms | Adult Aged Aged, 80 and over Bacterial Toxins - analysis Bacteriology Biological and medical sciences Clostridium difficile - isolation & purification Clostridium Infections - diagnosis Diagnostic Tests, Routine - methods Diarrhea - diagnosis Enzyme-Linked Immunosorbent Assay - methods Feces - chemistry Female Fundamental and applied biological sciences. Psychology Humans Infectious diseases Leukocyte L1 Antigen Complex - analysis Male Medical sciences Microbiology Middle Aged Miscellaneous ROC Curve Sensitivity and Specificity Young Adult |
| Title | Is there any value in measuring faecal calprotectin in Clostridium difficile positive faecal samples? |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/24464697 https://www.proquest.com/docview/1510090500 |
| Volume | 63 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVBFR databaseName: Free Medical Journals customDbUrl: eissn: 1473-5644 dateEnd: 20241105 omitProxy: true ssIdentifier: ssj0017339 issn: 0022-2615 databaseCode: DIK dateStart: 19680101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher – providerCode: PRVFQY databaseName: GFMER Free Medical Journals customDbUrl: eissn: 1473-5644 dateEnd: 20241105 omitProxy: true ssIdentifier: ssj0017339 issn: 0022-2615 databaseCode: GX1 dateStart: 19680101 isFulltext: true titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php providerName: Geneva Foundation for Medical Education and Research |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKEAgJIRiXlctkJBAPVTo3cZz5CaGxaYN1INFKfYtsx9UimrQj6cN45JdzbOdW2KSBIkWVZbtVv88n34mPz0Hozb7mifKp9ljEBTgosKQkrG8vmks_EVIl3B4fG5-x4yn9NAtnvd6vTtTSupRD9fPKcyX_gyq0Aa7mlOw_INtMCg3wGfCFOyAM9xthfFIY3Wh3AC4HJm23zQCS2dd-NkJSaJv_QyyqdAypjWs8WCxNtY4kXWe2QEqqwDQMXPiWSQLuRhXCJA4u_oj86wjYrNrjydI2mVNr40HKnlf8-QZ8yDv7T-dpfeThMyjdzlmI5XLlGDROvzeEs1OYMCLdfUMx6ga2OKNKo8ALmcvzONRXtFWWuDJ1jnFfywHtWNbQVRX9y-KDwjUWP8uGZGiK7pgIsPbZVu_nn32Jj6anp_HkcDaBJbW68EzdMbM__zb46IhxC9324clgy3_MmjChURTYanTN720Sf_K9zS_dEDb3V6IABOauOMr13otVMZOH6EGFHv7guPQI9XS-je64gqSX2-juuAq1eIz0SYEtuTCQC1ty4TTHDbmwownukst06JALN-TCNbnqURW53j9B06PDycGxV9Xk8FTgh6UnEqrJHESMECDlQb5K8DD8hKqEwKVH0hdBkGjwCwThESdMgiSX4JeSfSXnoQqeoq18mesdhIMIrhEPtWJzyojgzJdMcUETIpJIsj7y6j80VlXCelM3ZRG7wAkeAwAxiR0AMemjd03_lUvVcm3P3Q18mu6-cRdAIPfR6xqwGMyt2UMTuV6uixgEMnglJCQwyTOHZDuaUkYZj57fYPQLdK9dKi_RVvljrV-BvC3lruXfbwXCqOU |
| linkProvider | Geneva Foundation for Medical Education and Research |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Is+there+any+value+in+measuring+faecal+calprotectin+in+Clostridium+difficile+positive+faecal+samples%3F&rft.jtitle=Journal+of+medical+microbiology&rft.au=Whitehead%2C+Simon+J&rft.au=Shipman%2C+Kate+E&rft.au=Cooper%2C+Mike&rft.au=d%2C+Clare&rft.date=2014-04-01&rft.issn=1473-5644&rft.eissn=1473-5644&rft.volume=63&rft.issue=Pt+4&rft.spage=590&rft_id=info:doi/10.1099%2Fjmm.0.067389-0&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-2615&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-2615&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-2615&client=summon |